US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 8.130
  • +0.240+3.04%
Trading May 22 13:43 ET
518.71MMarket Cap-8468P/E (TTM)

About Larimar Therapeutics Company

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Company Profile

SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carole Ben-Maimon, M.D.
  • Director, President and Chief Executive Officer
  • 3.14M
  • Dr. Russell G. Clayton, D.O.
  • Chief Medical Officer
  • --
  • Michael Celano
  • Chief Financial Officer and Principal Accounting Officer
  • 1.42M
  • Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
  • Chief Development Officer
  • 1.38M
  • Joseph Truitt
  • Chairman of the Board
  • 114.96K
  • Thomas Edward Hamilton
  • Independent Director
  • 77.77K
  • Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
  • Independent Director
  • 56.43K
  • Jonathan S. Leff
  • Independent Director
  • 79.96K
  • Frank E. Thomas
  • Independent Director
  • 86.21K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg